Next Article in Journal
Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients
Next Article in Special Issue
Aberrant Sialylation in Cancer: Therapeutic Opportunities
Previous Article in Journal
The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
Previous Article in Special Issue
The B-Cell-Specific Ablation of B4GALT1 Reduces Cancer Formation and Reverses the Changes in Serum IgG Glycans during the Induction of Mouse Hepatocellular Carcinoma
 
 
Review

Article Versions Notes

Cancers 2022, 14(9), 2128; https://doi.org/10.3390/cancers14092128
Action Date Notes Link
article pdf uploaded. 24 April 2022 12:22 CEST Version of Record https://www.mdpi.com/2072-6694/14/9/2128/pdf-vor
article supplementary file uploaded. 24 April 2022 12:22 CEST - https://www.mdpi.com/2072-6694/14/9/2128#supplementary
article xml file uploaded 25 April 2022 05:15 CEST Original file -
article xml uploaded. 25 April 2022 05:15 CEST Update -
article pdf uploaded. 25 April 2022 05:15 CEST Updated version of record https://www.mdpi.com/2072-6694/14/9/2128/pdf-vor
article html file updated 25 April 2022 05:16 CEST Original file -
article xml file uploaded 25 April 2022 05:17 CEST Update -
article xml uploaded. 25 April 2022 05:17 CEST Update https://www.mdpi.com/2072-6694/14/9/2128/xml
article pdf uploaded. 25 April 2022 05:17 CEST Updated version of record https://www.mdpi.com/2072-6694/14/9/2128/pdf
article html file updated 25 April 2022 05:18 CEST Update -
article html file updated 25 April 2022 10:10 CEST Update -
article html file updated 2 August 2022 20:34 CEST Update https://www.mdpi.com/2072-6694/14/9/2128/html
Back to TopTop